​

AdaptHealth (AHCO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AHCO Stock Forecast

AdaptHealth (AHCO) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $14.40, with a high of $18.00 and a low of $11.00. This represents a 42.57% increase from the last price of $10.10.

$5 $8 $11 $14 $17 $20 High: $18 Avg: $14.4 Low: $11 Last Closed Price: $10.1

AHCO Stock Rating

AdaptHealth stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (75.00%), 2 Hold (16.67%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 2 9 Strong Sell Sell Hold Buy Strong Buy

AHCO Price Target Upside V Benchmarks

TypeNameUpside
StockAdaptHealth42.57%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks32.91%

Price Target Trends

1M3M12M
# Anlaysts-46
Avg Price Target-$15.00$14.17
Last Closing Price$10.10$10.10$10.10
Upside/Downside-48.51%40.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26152--8
May, 26152--8
Apr, 26152--8
Mar, 26152--8
Feb, 26152--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 11, 2026RBC Capital$15.00$11.5330.10%48.51%
May 06, 2026Canaccord Genuity$16.00$11.7536.17%58.42%
May 06, 2026Eric ColdwellRobert W. Baird$18.00$11.7553.19%78.22%
Apr 20, 2026Brian TanquilutJefferies$11.00$12.73-13.59%8.91%
Feb 26, 2026Whit MayoLeerink Partners$12.00$9.3328.62%18.81%
Feb 25, 2026Ben HendrixRBC Capital$13.00$8.9145.90%28.71%
Nov 15, 2024David MacDonaldTruist Financial$12.00$9.8022.45%18.81%
Nov 06, 2024Eric ColdwellRobert W. Baird$14.00$9.0754.36%38.61%
Sep 23, 2024Eric ColdwellRobert W. Baird$16.00$11.4240.11%58.42%
Aug 08, 2024Kevin CaliendoUBS$13.00$9.5336.41%28.71%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 11, 2026RBC CapitalOutperformOutperformhold
Apr 20, 2026JefferiesHoldHoldhold
Feb 26, 2026Leerink PartnersOutperformOutperformhold
Feb 25, 2026RBC CapitalOutperformOutperformhold
Aug 08, 2024UBSBuyBuyhold
May 15, 2024UBSBuyBuyhold
Mar 04, 2024UBSBuyBuyhold
Sep 20, 2022Deutsche BankBuyBuyhold
Sep 19, 2022SusquehannaBuyBuyhold
Aug 10, 2022RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.12$0.52$-5.32$0.62$-0.52---
Avg Forecast$1.17$0.86$0.80$0.92$1.00$1.19$1.39$1.64
High Forecast$1.19$0.89$1.20$0.96$1.07$1.59$1.44$1.70
Low Forecast$1.16$0.85$-0.26$0.89$0.96$0.80$1.36$1.61
Surprise %-4.27%-39.53%-765.00%-32.61%-152.00%---

Revenue Forecast

$2B $3B $4B $5B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45B$2.97B$3.20B$3.26B$3.24B---
Avg Forecast$2.44B$2.98B$3.17B$3.23B$3.33B$3.51B$5.43B$6.20B
High Forecast$2.46B$3.04B$3.25B$3.24B$3.42B$3.51B$5.58B$6.37B
Low Forecast$2.41B$2.94B$3.16B$3.22B$3.28B$3.51B$5.35B$6.11B
Surprise %0.62%-0.26%1.04%0.85%-2.54%---

Net Income Forecast

$-1B $-700M $-400M $-100M $200M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$156.18M$69.32M$-678.89M$90.42M$-70.79M---
Avg Forecast$266.42M$194.60M$-678.89M$124.32M$136.45M$144.71M$186.84M$220.45M
High Forecast$322.81M$233.52M$-543.12M$128.82M$143.30M$213.18M$193.51M$228.32M
Low Forecast$210.03M$155.68M$-814.67M$119.81M$129.60M$107.26M$183.09M$216.01M
Surprise %-41.38%-64.38%--27.26%-151.88%---

AHCO Forecast FAQ

Is AdaptHealth stock a buy?

AdaptHealth stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that AdaptHealth is a favorable investment for most analysts.

What is AdaptHealth's price target?

AdaptHealth's price target, set by 12 Wall Street analysts, averages $14.4 over the next 12 months. The price target range spans from $11 at the low end to $18 at the high end, suggesting a potential 42.57% change from the previous closing price of $10.1.

How does AdaptHealth stock forecast compare to its benchmarks?

AdaptHealth's stock forecast shows a 42.57% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (32.91%).

What is the breakdown of analyst ratings for AdaptHealth over the past three months?

  • June 2026: 12.50% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 12.50% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 12.50% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is AdaptHealth’s EPS forecast?

AdaptHealth's average annual EPS forecast for its fiscal year ending in December 2026 is $1.19, marking a -328.85% decrease from the reported $-0.52 in 2025. Estimates for the following years are $1.39 in 2027, and $1.64 in 2028.

What is AdaptHealth’s revenue forecast?

AdaptHealth's average annual revenue forecast for its fiscal year ending in December 2026 is $3.51B, reflecting a 8.27% increase from the reported $3.24B in 2025. The forecast for 2027 is $5.43B, and $6.2B for 2028.

What is AdaptHealth’s net income forecast?

AdaptHealth's net income forecast for the fiscal year ending in December 2026 stands at $144.71M, representing a -304.41% decrease from the reported $-70.794M in 2025. Projections indicate $186.84M in 2027, and $220.45M in 2028.